<DOC>
	<DOCNO>NCT00542464</DOCNO>
	<brief_summary>The study Phase Ib , randomize , double-blind , placebo-controlled , multiple-dose ( 7 day ) , dose-escalation study assess safety , pharmacodynamics , pharmacokinetics intravenous Imprime PGG™ Injection healthy adult subject .</brief_summary>
	<brief_title>Multiple-Dose , Dose-Escalation Safety , Pharmacodynamics , Pharmacokinetics Study Imprime PGG™ Injection</brief_title>
	<detailed_description />
	<criteria>1 . Be age 18 45 year , inclusive 2 . Have body weight 45 125 kg , inclusive , body mass index less equal 30 kg/m2 3 . If female , nonpregnant nonnursing , premenopausal , negative serum pregnancy test confirm prior enrollment practice least two method birth control 4 . Be healthy determine investigator basis medical history , physical examination , electrocardiogram , clinical laboratory test result 5 . Have ability understand requirement study , provide write informed consent , agree abide study restriction return require assessment 6 . Have provide write authorization use disclosure protect health information 1 . Have know hypersensitivity baker 's yeast 2 . Have history tobacco use within 3 month first day screen 3 . Be know suspected abuser alcohol drugs/substances abuse anytime 4 . Have active yeast infection 5 . Have positive hepatitis B , hepatitis C , human immunodeficiency virus ( HIV ) test conduct part screen 6 . Except otherwise indicate , take prescription medication within 30 day last day screen ( Day 1 ) overthecounter medication , herbal preparation , vitamin within 7 day last day screen ( Day 1 ) ; follow medication exempt criterion : acetaminophen [ maximum 3 g/day ] , female hormone replacement therapy , oral contraceptive 7 . Have participate investigational drug study within 30 day five half life ( whichever longer ) last day screen ( Day 1 ) ever participate study Imprime PGG Betafectin 8 . Have donate lose unit blood within 30 day last day screen ( Day 1 ) 9 . Have clinical condition , opinion principal investigator , warrant exclusion study scientific , procedural , safety perspective</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Safety Healthy Adult Subjects</keyword>
</DOC>